
Bone turnover markers in the early stage of rapidly progressive osteoarthritis of the hip
Author(s) -
Tadashi Yasuda,
Kazuhiro Matsunaga,
Takumi Hashimura,
Yoshihiro Tsukamoto,
Tatsuya Sueyoshi,
Satoshi Ota,
Satoshi Fujita,
Eijiro Onishi
Publication year - 2021
Publication title -
european journal of rheumatology :/european journal of rheumatology
Language(s) - English
Resource type - Journals
eISSN - 2147-9720
pISSN - 2148-4279
DOI - 10.5152/eurjrheum.2020.20046
Subject(s) - bone remodeling , medicine , osteoarthritis , femoral head , n terminal telopeptide , stage (stratigraphy) , pathology , endocrinology , alkaline phosphatase , osteocalcin , surgery , chemistry , biology , biochemistry , paleontology , alternative medicine , enzyme
Previous reports have demonstrated that patients with end-stage rapidly progressive osteoarthritis of the hip (RPOH) show significantly higher serum levels of bone turnover markers than those with osteoarthritis (OA). However, the characteristics of bone turnover markers in the early stage of RPOH remain unclear. This study aimed to elucidate the association of bone turnover markers with disease progression in the early stage of RPOH.